Inventor · disambiguated record
Abdessatar Chtourou
Also filed as: CHTOUROU ABDESSATAR · CHTOUROU ABDESSATAR SAMI
14 granted patents·21 pending applications·127 citations·filing 1998–2019
91Inventor score
Files withLAB FRANCAIS DU FRACTIONNEMENT20CHTOUROU ABDESSATAR2CHTOUROU ABDESSATAR SAMI2FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES S A LAB2LFB BIOTECHNOLOGIES2
Top patents by PatentIndex Score
35 records- 0187US7186410B2Method for preparing human immunoglobulin concentrates for therapeutic useLABORATOIORE FRANCAIS DU FRACT·Filed 2002·Granted Mar 6, 2007·64 cites·33 claims
- 0281US10611826B2Affinity chromatography matrixLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Apr 7, 2020·4 cites·17 claims
- 0381US8153382B2Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGsCHTOUROU ABDESSATAR·Filed 2006·Granted Apr 10, 2012·10 cites·12 claims
- 0480US8383104B2Thrombin-free biological adhesive and use thereof as a medicamentLAB FRANCAIS DU FRACTIONNEMENT·Filed 2006·Granted Feb 26, 2013·3 cites·22 claims
- 0575US10364425B2Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan unitsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Jul 30, 2019·2 cites·11 claims
- 0674US10344272B2Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan unitsCHTOUROU ABDESSATAR SAMI·Filed 2007·Granted Jul 9, 2019·2 cites·10 claims
- 0774US7932355B2Virally-safe factor VIII with a low content of higher multimersLFB SA·Filed 2004·Granted Apr 26, 2011·13 cites·5 claims
- 0871US8802620B2Demannosylated recombinant factor VIII for the treatment of patients with haemophilia ACHTOUROU ABDESSATAR SAMI·Filed 2008·Granted Aug 12, 2014·6 cites·16 claims
- 0967US9718856B2Method for preparing a concentrate of polyvalent immunoglobulinCHTOUROU ABDESSATAR·Filed 2012·Granted Aug 1, 2017·4 cites·21 claims
- 1066US2009239788A1Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated formsLFB BIOTECHNOLOGIES·Filed 2007·Application pending·0 cites
- 1164US6967239B1Method of filtering viruses from a factor VIII solutionFRANCIAS DU FRANCTIONNEMENT ET·Filed 1998·Granted Nov 22, 2005·19 cites·13 claims
- 1260US2020331994A1Oral composition of anti-tnf alpha antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2019·Application pending·0 cites
- 1357US2013149292A1Thrombin-free biological adhesive and use thereof as a medicamentBIOTECHNOLOGIES S A LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES·Filed 2012·Application pending·0 cites
- 1456US2013189244A1Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated formsLFB BIOTECHNOLOGIES·Filed 2012·Application pending·0 cites
- 1553US9175034B2Method for purifying or detecting a target proteinSIRET LAURENT·Filed 2008·Granted Nov 3, 2015·0 cites·18 claims
- 1650US2015328362A1Thrombin-free biological adhesive and use thereof as a medicamentFRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES S A LAB·Filed 2015·Application pending·0 cites
- 1750US2015328291A1Thrombin-free biological adhesive and use thereof as a medicamentFRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES S A LAB·Filed 2015·Application pending·0 cites
- 1849US2009317373A1Inhibition of the Anti-FVIII Immune ResponseINST NAT SANTE RECH MED·Filed 2006·Application pending·0 cites
- 1946US2020095326A1Combination of ant-cd303 and anti-amhrii antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Application pending·0 cites
- 2044US12247076B2Use of modified Fc fragments in immunotherapyLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted Mar 11, 2025·0 cites·8 claims
- 2144US2016089422A1Method for inactivating a prion proteinLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Application pending·0 cites
- 2244US2021024616A1Method for Purifying Antibodies from Raw MilkLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 2344US2016009761A1Method for purifying or detecting a target proteinLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Application pending·0 cites
- 2442US9982247B2Method for purifying transgenic factor VII/VIIALAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted May 29, 2018·0 cites·17 claims
- 2542US2018169297A1Injectable composition of factor vii and fillersLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Application pending·0 cites
- 2642US2018142036A1Composition enriched in anti-a and/or anti-b polyclonal immunoglobulins for use in the treatment of autoimmune diseases or polycythemiaLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Application pending·0 cites
- 2741US2017121402A1Oral composition of anti-tnf alpha antibodiesLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES·Filed 2015·Application pending·0 cites
- 2840US2019330369A1Combination of anti-cd303 and anti-her2 antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Application pending·0 cites
- 2939US2019338269A1Factor x variantsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Application pending·0 cites
- 3038US10357512B2Method for preparing universal plasmaLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jul 23, 2019·0 cites·11 claims
- 3138US2019002537A1Method for enriching a preparation of immunoglobulins with anti rsv immunoglobulins and preparation enriched in this wayLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Application pending·0 cites
- 3238US2019002567A1New use of an anti-cd303 transmembrane protein antibodyLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Application pending·0 cites
- 3334US2017296694A1Biological glue and use thereof as a medicamentLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Application pending·0 cites
- 3434US2017079928A1Copolymers of formula (i) and usesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Application pending·0 cites
- 3530US2017073396A1Method for preparing human plasma proteinsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →